We are live on
!
Find out more
Ray Dalio Bridgewater Associates
AUM
$22.4B
1-Year Est. Return
34.48%
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
This Fund
S&P 500
1 Year Est. Return
+34.48%
AUM
$22.4B
AUM Growth
-$5.02B
(-18%)
Holding
1,254
Top Buys
| 1 | +$537M | |
| 2 | +$371M | |
| 3 | +$230M | |
| 4 |
Broadcom
AVGO
|
+$220M |
| 5 |
NVIDIA
NVDA
|
+$152M |
Top Sells
| 1 | +$1.03B | |
| 2 | +$512M | |
| 3 | +$370M | |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Lam Research
LRCX
|
+$329M |
Sector Composition
| 1 | Technology | 29.25% |
| 2 | Industrials | 8.69% |
| 3 | Consumer Discretionary | 7.6% |
| 4 | Financials | 6.79% |
| 5 | Healthcare | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Range Resources
RRC
$8.65B
| $6M | 0.03% |
132,872
+81,116
|
|
||
377
Zoetis
ZTS
$32.2B
| $6M | 0.03% |
50,739
-131,820
|
|
||
378
Arrowhead Research
ARWR
$11.3B
| $5.99M | 0.03% |
95,552
+35,586
|
|
||
379
Vertex Pharmaceuticals
VRTX
$119B
| $5.96M | 0.03% |
13,357
-14,131
|
|
||
380
NETSCOUT
NTCT
$2.91B
| $5.95M | 0.03% |
187,312
+10,150
|
|
||
381
Semtech
SMTC
$15.2B
| $5.92M | 0.03% |
+76,935
|
|
||
382
Albemarle
ALB
$17.7B
| $5.91M | 0.03% |
+32,926
|
|
||
383
Starbucks
SBUX
$115B
| $5.89M | 0.03% |
65,739
-16,043
|
|
||
384
OneMain Financial
OMF
$6.71B
| $5.87M | 0.03% |
109,752
-56,765
|
|
||
385
Adient
ADNT
$1.61B
| $5.86M | 0.03% |
290,099
-139,181
|
|
||
386
WSFS Financial
WSFS
$3.96B
| $5.85M | 0.03% |
+89,339
|
|
||
387
Assured Guaranty
AGO
$3.46B
| $5.82M | 0.03% |
71,447
-50,698
|
|
||
388
Post Holdings
POST
$4.03B
| $5.82M | 0.03% |
58,852
-4,380
|
|
||
389
West Pharmaceutical
WST
$23.8B
| $5.81M | 0.03% |
23,161
+19,088
|
|
||
390
Idexx Laboratories
IDXX
$42.7B
| $5.8M | 0.03% |
10,314
+4,156
|
|
||
391
TTM Technologies
TTMI
$22.1B
| $5.77M | 0.03% |
59,223
+42,561
|
|
||
392
Everest Group
EG
$13.6B
| $5.75M | 0.03% |
17,580
-54,503
|
|
||
393
Ameren
AEE
$30.9B
| $5.72M | 0.03% |
52,064
-71,627
|
|
||
394
Barclays
BCS
$91.2B
| $5.61M | 0.03% |
+265,167
|
|
||
395
Lyft
LYFT
$5.25B
| $5.61M | 0.03% |
+421,670
|
|
||
396
Genpact
G
$4.79B
| $5.61M | 0.03% |
150,536
-299,622
|
|
||
397
Modine Manufacturing
MOD
$14.7B
| $5.56M | 0.02% |
+25,646
|
|
||
398
Crown Holdings
CCK
$11.8B
| $5.55M | 0.02% |
55,409
-16,312
|
|
||
399
Polaris
PII
$3.91B
| $5.55M | 0.02% |
101,800
+12,925
|
|
||
400
RPM International
RPM
$13.5B
| $5.53M | 0.02% |
55,589
-31,799
|
|